Compare Unichem Lab with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs AJANTA PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB AJANTA PHARMA UNICHEM LAB/
AJANTA PHARMA
 
P/E (TTM) x -102.4 22.5 - View Chart
P/BV x 0.6 3.9 14.5% View Chart
Dividend Yield % 2.5 0.9 270.5%  

Financials

 UNICHEM LAB   AJANTA PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
AJANTA PHARMA
Mar-19
UNICHEM LAB/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs2921,422 20.5%   
Low Rs182898 20.3%   
Sales per share (Unadj.) Rs167.7233.5 71.8%  
Earnings per share (Unadj.) Rs-3.644.0 -8.3%  
Cash flow per share (Unadj.) Rs5.952.2 11.4%  
Dividends per share (Unadj.) Rs4.009.00 44.4%  
Dividend yield (eoy) %1.70.8 217.5%  
Book value per share (Unadj.) Rs372.3255.1 145.9%  
Shares outstanding (eoy) m70.3888.02 80.0%   
Bonus/Rights/Conversions ESOPBB-  
Price / Sales ratio x1.45.0 28.5%   
Avg P/E ratio x-65.326.4 -247.4%  
P/CF ratio (eoy) x39.922.2 179.4%  
Price / Book Value ratio x0.64.5 14.0%  
Dividend payout %-110.220.5 -538.2%   
Avg Mkt Cap Rs m16,680102,081 16.3%   
No. of employees `0002.66.8 38.3%   
Total wages/salary Rs m2,3934,307 55.6%   
Avg. sales/employee Rs Th4,535.23,022.6 150.0%   
Avg. wages/employee Rs Th919.8633.4 145.2%   
Avg. net profit/employee Rs Th-98.2569.1 -17.3%   
INCOME DATA
Net Sales Rs m11,80120,554 57.4%  
Other income Rs m984211 466.8%   
Total revenues Rs m12,78520,765 61.6%   
Gross profit Rs m-8355,664 -14.7%  
Depreciation Rs m674721 93.5%   
Interest Rs m7512 648.3%   
Profit before tax Rs m-6005,143 -11.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-3431,273 -27.0%   
Profit after tax Rs m-2563,870 -6.6%  
Gross profit margin %-7.127.6 -25.7%  
Effective tax rate %57.324.8 231.4%   
Net profit margin %-2.218.8 -11.5%  
BALANCE SHEET DATA
Current assets Rs m20,38411,812 172.6%   
Current liabilities Rs m5,0293,776 133.2%   
Net working cap to sales %130.139.1 332.8%  
Current ratio x4.13.1 129.6%  
Inventory Days Days10577 135.4%  
Debtors Days Days13582 165.3%  
Net fixed assets Rs m9,02314,398 62.7%   
Share capital Rs m141175 80.3%   
"Free" reserves Rs m26,05822,277 117.0%   
Net worth Rs m26,19922,452 116.7%   
Long term debt Rs m07 0.0%   
Total assets Rs m31,49626,962 116.8%  
Interest coverage x-7.0444.3 -1.6%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.40.8 49.1%   
Return on assets %-0.614.4 -4.0%  
Return on equity %-1.017.2 -5.7%  
Return on capital %-2.023.0 -8.7%  
Exports to sales %69.40-   
Imports to sales %00-   
Exports (fob) Rs m8,188NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m8,18810,682 76.7%   
Fx outflow Rs m5962,102 28.4%   
Net fx Rs m7,5928,580 88.5%   
CASH FLOW
From Operations Rs m-3,2783,748 -87.5%  
From Investments Rs m-2,860-2,228 128.4%  
From Financial Activity Rs m-24-1,475 1.6%  
Net Cashflow Rs m-4,69045 -10,376.5%  

Share Holding

Indian Promoters % 50.1 73.8 67.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 1.6 974.2%  
FIIs % 3.0 7.6 39.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 17.0 186.5%  
Shareholders   20,176 20,968 96.2%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   DISHMAN PHARMA  CADILA HEALTHCARE  VENUS REMEDIES  DR. DATSONS LABS  GLENMARK PHARMA  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 21 Points Higher; Banking and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended their day marginally higher.

Related Views on News

AJANTA PHARMA Announces Quarterly Results (2QFY20); Net Profit Down 7.2% (Quarterly Result Update)

Nov 8, 2019 | Updated on Nov 8, 2019

For the quarter ended September 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (down 7.2% YoY). Sales on the other hand came in at Rs 6 bn (up 18.1% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 8.4% (Quarterly Result Update)

Aug 2, 2019 | Updated on Aug 2, 2019

For the quarter ended June 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 8.4% YoY). Sales on the other hand came in at Rs 6 bn (up 19.8% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

AJANTA PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of AJANTA PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AJANTA PHARMA. Also includes updates on the valuation of AJANTA PHARMA.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Ditch the Risky Fixed Deposits for Safer 'Bluechip Deposits'(Profit Hunter)

Oct 30, 2019

Most people think stocks are riskier than fixed deposits and bonds. The last quarter century proves otherwise.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Nov 11, 2019 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS